600064 南京高科
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,061,049274.09%1,980,2574,733,0384,490,0614,934,527
减:营业总成本998,200220.63%1,982,3134,564,9614,095,9564,688,834
    其中:营业成本839,208284.77%1,543,1954,143,8663,649,0473,797,987
               财务费用46,007-19.69%209,022220,384177,024203,312
               资产减值损失(23)--(773,775)(608,242)(2,743)(72,938)
公允价值变动收益(33,289)-48.27%24,779(140,770)(242,623)(34,410)
投资收益681,93115.84%2,293,6151,964,6752,405,3342,367,123
    其中:对联营企业和合营企业的投资收益672,56115.84%2,129,4471,829,7262,096,3341,686,458
营业利润702,79841.16%1,504,9841,367,5402,650,4142,679,073
利润总额704,66241.54%1,507,9231,369,9622,651,6352,679,209
减:所得税费用4,804-117.42%(133,472)(112,586)171,739276,924
净利润699,85833.20%1,641,3951,482,5492,479,8952,402,285
减:非控股权益7,722-1,914.96%(83,835)(77,597)77,52250,232
股东净利润692,13631.62%1,725,2301,560,1462,402,3742,352,053

市场价值指针
每股收益 (元) *0.40031.58%0.9970.9021.3881.359
每股派息 (元) *----0.3000.2800.4200.600
每股净资产 (元) *11.1476.31%10.86910.1369.572--
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容